PIUR IMAGING: Kevin Goodwin joins as Strategic Advisor to support U.S. expansion
PIUR IMAGING has appointed ultrasound industry pioneer Kevin Goodwin as Strategic Advisor. The former Sonosite founder and CEO will support the company's U.S. commercial expansion, international growth strategy and upcoming financing activities as PIUR scales its AI-powered 3D ultrasound platform.
PIUR IMAGING announced that Kevin Goodwin has joined the company as Strategic Advisor. With more than 35 years of experience in ultrasound technologies and AI-enabled medical imaging, Goodwin brings extensive expertise in building global healthcare businesses, commercialising innovative technologies and supporting high-growth MedTech companies.
His appointment comes as PIUR advances its U.S. commercial rollout following FDA clearance and prepares for its next major growth financing round.
Transforming conventional ultrasound into AI-powered 3D imaging
PIUR IMAGING has developed a vendor-agnostic, FDA-cleared add-on technology that transforms conventional 2D ultrasound systems into tomographic 3D imaging platforms. Combined with AI-powered image analysis, the technology delivers reproducible organ-level volumetric data, helping clinicians reduce operator dependency and improve diagnostic confidence.
Industry expertise to support the next growth phase
Kevin Goodwin is widely recognised as one of the pioneers of point-of-care ultrasound (POCUS). After founding Sonosite following its 1998 spin-off from ATL Ultrasound, he led the company from an early-stage startup to the global market leader in portable ultrasound before its acquisition by FUJIFILM in 2012 for nearly one billion US dollars.
He later co-founded EchoNous, where he helped develop the AI-powered Kosmos POCUS platform, further advancing the integration of artificial intelligence into diagnostic ultrasound.
“Having Kevin Goodwin in our corner is a genuine game-changer. He didn’t just witness the transformation of diagnostic ultrasound, he led it, twice. Kevin understands exactly what it takes to build a category-defining medical technology company and get it to scale. His conviction in PIUR’s technology and our U.S. market opportunity validates everything we have been building toward. With Kevin’s guidance, we are ready to move from breakthrough innovation to breakout commercial success,” said Frederik Bender, CEO & Managing Director of PIUR IMAGING.
Supporting commercial expansion and fundraising
PIUR has already achieved FDA clearance and CE marking, established its U.S. subsidiary and secured its first commercial partnerships, including the integration of its PIUR tUS inside technology into selected GE HealthCare LOGIQ ultrasound systems.
As Strategic Advisor, Kevin Goodwin will focus on three strategic priorities:
- Supporting the company's U.S. commercial strategy and customer acquisition.
- Strengthening investor positioning and contributing to the next financing round.
- Supporting operational scaling, international expansion and OEM partnerships.
“I have spent my entire career trying to make ultrasound more useful, more accessible, and more reliable. When I first encountered PIUR’s technology, I immediately recognized what the team has built: a genuinely transformative solution that makes 3D tomographic imaging available everywhere, with any scanner. This is the next great leap for the field, and a compelling commercial and investment opportunity. I’m proud to help PIUR bring it to scale,” said Kevin Goodwin.
About PIUR IMAGING
PIUR IMAGING is an ISO 13485-certified and FDA-cleared MedTech company with offices in Austria, Germany and the United States. The company develops AI-powered 3D ultrasound solutions designed to improve clinical workflows and enable scalable, reproducible and efficient diagnostic imaging.
Contact
Stacey Hong
Event Marketing Manager
PIUR IMAGING GmbH
E-mail: pr@piurimaging.com